Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica - sprookjes - yvandenbroek - TriplyDB

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

http://www.wikidata.org/entity/Q21144670

about

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management Update on biomarkers in neuromyelitis optica Principles of separation: indications and therapeutic targets for plasma exchange.Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.[Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography].Diagnostic biomarkers in multiple sclerosis.[Ultrahigh field MRI in context of neurological diseases].Neuromyelitis optica: clinical features, immunopathogenesis and treatment.[Contribution of spinal cord biopsy to the differential diagnosis of longitudinal extensive transverse myelitis].Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance Interferon-β exacerbates Th17-mediated inflammatory disease.Rapid induction of autoantibodies during ARDS and septic shock.Treatment of neuromyelitis optica: current debate.Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).New insights into neuromyelitis optica Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.Evaluation of aquaporin-4 antibody assays.Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging

P2860

Q21093230-6FDDE06E-8AE4-449E-A978-DCA9B35A5523 Q26767391-4C4F1B6C-3627-45E7-8F4E-4B90733E7958 Q26796643-98EF95FF-FE73-45A7-AC32-8ED67CB0E035 Q26799789-B724A2EF-3BA9-4386-BB9F-E5457CB2B959 Q26830899-5DB88FBC-DCE3-4F90-958F-2EFCAE9FD368 Q28728565-CA79C945-C5AB-433E-B5AC-C76480C72BF4 Q30371412-33D17379-FE42-4CBA-9803-801B2DCE4EB8 Q30585550-32E7C9D9-A3BF-4397-95C0-F2D471428698 Q30591135-CBB1DE8D-F688-4ACC-B56D-B1FCAA28F27B Q30598338-431ABCBE-D03E-471D-BB17-BC3FFE3AB1F9 Q30759627-648981A6-F60B-4981-8468-3A9937A3DA26 Q30785267-21703E49-98E8-4B4A-A3F0-7AF3C598187D Q30844319-15495BF5-7F25-4EC8-ACC1-F096D06DD34B Q33419781-987B27A1-A9D9-4B32-8F84-C4DBD81352DF Q33734731-79A3F237-74D1-4DCD-B491-81E68525A2D8 Q33895664-8FD800D6-FB13-4C77-BCA2-B4CA8BEC0A2C Q34026880-8C8AC8F1-911E-4875-AAD8-28DA1B3135E1 Q34138884-3BFC14E2-3E91-4B1D-B3BE-E334982FF7F1 Q34154277-3959A0F1-8247-48B7-AF8F-507128BDDB12 Q34181184-E437D3AA-4CAB-4C5A-B4E8-1D41D5B8E5B2 Q34267557-82932F46-C8B5-4769-83B4-22F05E896ECD Q34409070-4FC47AAA-E422-4D05-9D29-1F827077DA46 Q34785270-97E4C2CA-0053-42D9-9E00-E21BDF9AD187 Q35052199-B87977E9-DB0B-4898-AFE0-1271E5364947 Q35539641-2E4CBDE3-4E7D-4B6C-8788-CDE5BBA539F4 Q35722940-12A3E36A-72E5-443A-93F4-9261B5B88A26 Q35871686-E53C0E7B-F7E5-4368-B3E0-14A8DD812B90 Q35903957-7DB5C7F1-6857-4BE4-8E62-BAD6DA86230A Q36160086-43117108-F625-4DFD-9EF1-8267771710AA Q36171516-A2555854-DA3B-404E-B5AD-D77DC303C130 Q36183920-03640F94-E3B2-4943-A6D9-E014D81D785C Q36189702-5A0A0D2C-B2E6-4C2E-93DE-53AC8A7A10F4 Q36244588-A5631A31-6ED0-4EEA-B837-C8D977AC749C Q36648907-5DEFDFBA-4D16-4626-87E4-D15BA4E1E314 Q36961015-9D172DE1-C594-410A-9EF4-5CBB38C58240 Q37252524-64A6D19B-6133-42EC-81AC-15013513E69C Q37343843-26F1954A-E591-4CF4-A305-C5175F3D11DE Q37374434-81E9F2A2-9123-422E-A927-A22AB92D26B9 Q37404328-CFB61964-6DFA-4F7C-A3C2-2CD418CA1AB6 Q37442228-4E063A4B-68E0-4FAF-9963-FED45F6A23AA

P2860

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

http://www.wikidata.org/entity/Q21144670

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@ast

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en-gb

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@nl

type

label

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@ast

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en-gb

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@nl

prefLabel

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@ast

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en-gb

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@nl

P1433

Q21144670-39B57F0D-C4A4-436A-9D68-C384EB4B2F03

P1476

Q21144670-DA1CCE06-30FE-4EBF-891B-9C31FB1047AD

P2093

Q21144670-0496BEC3-C555-41A0-80F4-7C2CABCA2188

Q21144670-779FA533-9FAE-4492-8DD8-E8426D54A820

Q21144670-7F3B2A74-6C29-45BE-AE55-D29334ABC742

Q21144670-846F1A33-4CEE-406B-85BC-42DDE4C96086

Q21144670-96CE9D73-4F7B-41D6-A2E6-EE8A581236A2

Q21144670-A87A555C-F900-4485-BAB6-A42C802CCBED

Q21144670-F2965782-A3A2-419F-B7EC-F2E0598BC00E

P2860

Q21144670-07A28CF2-B570-4A85-9C5B-F330CF075BCF

Q21144670-2FC98B3E-A18F-4283-8AB8-BD94E4B3E596

Q21144670-62F4268A-CACC-4634-9653-233B237E8AA8

Q21144670-8C5A9082-1334-47E4-9213-D40DDA3CE911

Q21144670-93B4E4D1-6A15-45C7-88F5-A04D26796510

Q21144670-ACF955EE-18FB-4544-BF6D-8C988DE8655F

Q21144670-C2FB6D0C-D947-4A4B-84AA-C424EFFC4E06

Q21144670-CF67E655-B3DE-470C-9DC2-0E09F17E9CA6

Q21144670-D75D60AD-7667-42E7-80BF-8342DD83B353

Q21144670-E57D231C-56F7-4173-B3EF-600B3958B72B

P304

Q21144670-C73CA3B0-F6DC-4DCC-BE79-92266E22518E

P31

Q21144670-92B3B650-8944-466F-B280-397C19178E89

P3181

Q21144670-0275C7E1-318F-4822-9828-0A91B1EB2737

P356

Q21144670-7DBFE290-D77D-44EA-9BEA-8170EFF7CC02

P407

Q21144670-79D9A53D-3187-4C02-BA6F-625C8287C7B9

P433

Q21144670-D51459A6-83E1-4589-9600-4452FDD50D25

P478

Q21144670-DBDE0ADF-FD55-44B0-B6BC-A4087CA70A5F

P50

Q21144670-0EBFFAE5-4A85-4813-B03F-A2C4818FA2EC

Q21144670-3CDF6011-F633-4E8D-BB2C-17D2FBE93606

Q21144670-4B634392-C67F-4DA4-BBF8-B49E167BB318

Q21144670-64A54C09-3C6B-44AC-A52C-C33D989E3053

Q21144670-75A722B5-1198-44C3-AAFA-0C0169A00FAE

Q21144670-9FA1A625-E8B4-4F07-82A1-4337AC90535E

Q21144670-F7646914-093F-4557-9C1B-7131E5E1402C

P577

Q21144670-F900BAD3-903F-46A9-A187-5E2D47A2EB7B

P5875

Q21144670-F8FE20D6-FF70-4D53-BC5B-B98AECC76E71

P698

Q21144670-34AC57EA-0C37-4C3D-BD64-6AE262F9064A

P921

Q21144670-07dd70f7-8fbd-4867-a973-8e001627012c

Q21144670-3F7AB0D0-BBD2-47D0-9DAC-1D7DD2CEB01C

P932

Q21144670-0707ED04-5AEC-4292-9F83-0E0C1DB77F37

P3181

P356

JOURNAL.PMED.0040133

P1433

P1476

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

@en

P2093

Diego Franciotta

http://www.w3.org/2001/XMLSchema#string

Edward Littleton

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Seelig

http://www.w3.org/2001/XMLSchema#string

Heribert Appelhans

http://www.w3.org/2001/XMLSchema#string

Martin Bluthner

http://www.w3.org/2001/XMLSchema#string

Oliver Bauer

http://www.w3.org/2001/XMLSchema#string

Reinhard Hohlfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

The clinical course of neuromyelitis optica (Devic's syndrome).

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

Revised diagnostic criteria for neuromyelitis optica.

Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype.

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

A statistically defined endpoint titer determination method for immunoassays.

P304

e133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2861433

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0040133

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Friedemann Paul

Jacqueline Palace

Roberto Bergamaschi

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6389936

http://www.w3.org/2001/XMLSchema#string

P698

17439296

http://www.w3.org/2001/XMLSchema#string

P921

P932

1852124

http://www.w3.org/2001/XMLSchema#string